Curl, the open source tool that's like the oxygen in the internet's atmosphere, has turned 25 years old More here
Daniel Stenberg has observed the 25th anniversary of the curl open source project with the publication of curl 8.0.0, the 215th release of the command line tool, and a modest tele-celebration.to emphasize its function, stands for"Client for URLs" or"Client URL Request Library" or its recursive form,"curl URL Request Library."
Any developer who is serious about writing code that interacts over a network has probably used curl, or does so regularly. Presently, billions of devices rely on curl – cars, mobile phones, set top boxes, routers, and other such items use it internally for data transfer. As Stenberg explained, curl 4.0 supported just three protocols, HTTP, GOPHER and FTP, and 24 command line options. Version 8.0.0 can handle 28 protocols and 249 command line options.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Curl, the URL code that can, marks 25 years of transfersUtility that began as a personal project found its way into billions of devices
Read more »
Victim's father marks 30 years since Warrington IRA bombingDad whose 12-year-old son was killed by IRA bomb 30 years ago says campaigning for peace is 'glue which has kept the family together'
Read more »
Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance - Molecular CancerBackground Despite advances in early detection and therapies, cancer is still one of the most common causes of death worldwide. Since each tumor is unique, there is a need to implement personalized care and develop robust tools for monitoring treatment response to assess drug efficacy and prevent disease relapse. Main body Recent developments in liquid biopsies have enabled real-time noninvasive monitoring of tumor burden through the detection of molecules shed by tumors in the blood. These molecules include circulating tumor nucleic acids (ctNAs), comprising cell-free DNA or RNA molecules passively and/or actively released from tumor cells. Often highlighted for their diagnostic, predictive, and prognostic potential, these biomarkers possess valuable information about tumor characteristics and evolution. While circulating tumor DNA (ctDNA) has been in the spotlight for the last decade, less is known about circulating tumor RNA (ctRNA). There are unanswered questions about why some tumors shed high amounts of ctNAs while others have undetectable levels. Also, there are gaps in our understanding of associations between tumor evolution and ctNA characteristics and shedding kinetics. In this review, we summarize current knowledge about ctNA biology and release mechanisms and put this information into the context of tumor evolution and clinical utility. Conclusions A deeper understanding of the biology of ctDNA and ctRNA may inform the use of liquid biopsies in personalized medicine to improve cancer patient outcomes.
Read more »
An artificial intelligence approach for predicting death or organ failure after hospitalization for COVID-19: development of a novel risk prediction tool and comparisons with ISARIC-4C, CURB-65, qSOFA, and MEWS scoring systems - Respiratory ResearchBackground We applied machine learning (ML) algorithms to generate a risk prediction tool [Collaboration for Risk Evaluation in COVID-19 (CORE-COVID-19)] for predicting the composite of 30-day endotracheal intubation, intravenous administration of vasopressors, or death after COVID-19 hospitalization and compared it with the existing risk scores. Methods This is a retrospective study of adults hospitalized with COVID-19 from March 2020 to February 2021. Patients, each with 92 variables, and one composite outcome underwent feature selection process to identify the most predictive variables. Selected variables were modeled to build four ML algorithms (artificial neural network, support vector machine, gradient boosting machine, and Logistic regression) and an ensemble model to generate a CORE-COVID-19 model to predict the composite outcome and compared with existing risk prediction scores. The net benefit for clinical use of each model was assessed by decision curve analysis. Results Of 1796 patients, 278 (15%) patients reached primary outcome. Six most predictive features were identified. Four ML algorithms achieved comparable discrimination (P | 0.827) with c-statistics ranged 0.849–0.856, calibration slopes 0.911–1.173, and Hosmer–Lemeshow P | 0.141 in validation dataset. These 6-variable fitted CORE-COVID-19 model revealed a c-statistic of 0.880, which was significantly (P | 0.04) higher than ISARIC-4C (0.751), CURB-65 (0.735), qSOFA (0.676), and MEWS (0.674) for outcome prediction. The net benefit of the CORE-COVID-19 model was greater than that of the existing risk scores. Conclusion The CORE-COVID-19 model accurately assigned 88% of patients who potentially progressed to 30-day composite events and revealed improved performance over existing risk scores, indicating its potential utility in clinical practice.
Read more »
I paid off £30k in debt in five years - the six tips I swear byA WOMAN has revealed how she managed to pay off a whopping £30k of debt in just five years. Julie Haneline, who is from South Carolina, racked up the huge debt due to student loans, credit car…
Read more »